These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7449939)

  • 1. Antiarrhythmic and cardiovascular properties of 17-monochloroacetylajmaline (17-MCAA).
    Capra C; Cristoni A; Lietti A; Picci M; Santi-Soncin E
    Farmaco Prat; 1980 Feb; 35(2):49-70. PubMed ID: 7449939
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antiarrhythmic, cardiovascular and toxic effects of 4-[3'-diethylamino-2'-hydroxypropyl]-ajmaline (Tachmalcor) in comparison with ajmaline and propranolol].
    Terhaag B; Förster W; Mest HJ; Schrör K
    Pharmazie; 1976; 31(1):39-44. PubMed ID: 1257278
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings: Relation of antiarrhythmic to inotropic activity of ajmaline and its therapeutically used derivatives N-propylajmaline and di-monochloracetylajmaline.
    Raschak M
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R32. PubMed ID: 1143422
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular effects and blood concentrations of ajmaline and its 17-monochloroacetate ester in cats.
    Spilker B; Shargel L; Koss RF; Minatoya H
    Arch Int Pharmacodyn Ther; 1975 Jul; 216(1):63-78. PubMed ID: 1164107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antiarrhythmic, cardiovascular and toxic actions of N,N'-bis-[3-(2'-ethoxyphenoxy)-2-hydroxypropyl]-ethlenediamine (Falirytmin) as compared to propranolol, quinidine and ajmaline].
    Terhaag B; Förster W
    Pharmazie; 1976; 31(9):635-9. PubMed ID: 1019213
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of the antiarrhythmic action of ajmaline, N-n-propylajmalinehydrogen-tartrate and 4-[3'-diethylamino-2'-hydroxypropyl]-ajmalinehydrogentartrate (Tachmalcor) with their hemodynamic and cardiac side-effects].
    Femmer K; Grünheid K
    Pharmazie; 1976; 31(1):33-6. PubMed ID: 1257276
    [No Abstract]   [Full Text] [Related]  

  • 7. ACTH and alpha-MSH: cardiovascular and antiarrhythmic properties.
    Lindner E; Schölkens B
    Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):19-23. PubMed ID: 4367710
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: The potentiation of the antiarrhythmic effects of quinidine sulfate, lidocaine and ajmaline by tween 80.
    Rohte O; Jakovljević V
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R81. PubMed ID: 4276637
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics and antiarrhythmic activity of ajmaline in rats subjected to coronary artery occlusion.
    Hashimoto Y; Hori R; Okumura K; Yasuhara M
    Br J Pharmacol; 1986 May; 88(1):71-7. PubMed ID: 3708225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-n-propyl-ajmaline-bitartrate (NPAB), a new antiarrhythmic drug. Comparative studies on the antifibrillatory and hemodynamic effects in the anaesthetised cat.
    Diederich KW; Boyksen D
    Arzneimittelforschung; 1973 Sep; 23(9):1302-5. PubMed ID: 4801225
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cardiovascular effects of N-ethyl perhexiline maleate in animals].
    Meng HP; Zhang BH
    Yao Xue Xue Bao; 1985 Jun; 20(6):401-4. PubMed ID: 4096229
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neurologic complications of monochloroacetylajmaline poisoning].
    Pierini G; Pompili A; Tassani G; Bianchini LM; Mencarelli L; Cordella L
    Riv Neurobiol; 1982; 27(2):258-65. PubMed ID: 7123073
    [No Abstract]   [Full Text] [Related]  

  • 13. Electrophysiologic effects of new ester of ajmaline 17-monochloroacetyl ajmaline hydrochloride (MCAA).
    de Azevedo IM; Dreifus LS; Watanabe Y
    Eur J Cardiol; 1975 Jan; 2(3):321-5. PubMed ID: 1149769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Structure-activity relationship in various 4-substituted ajmaline derivatives].
    Femmer K; Gabsch G; Braun K
    Pharmazie; 1976; 31(1):36-9. PubMed ID: 1257277
    [No Abstract]   [Full Text] [Related]  

  • 15. [The anti-arrhythmia action of combinations of N-propylajmaline bromide with anti-arrhythmia agents of different classes].
    Gendenshteĭn EI; Balashov VP; Kostin IaV; Oleĭnikov VE
    Farmakol Toksikol; 1990; 53(1):30-2. PubMed ID: 1691716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic and hemodynamic effects of prifuroline.
    Benharkate M; Plassard G; Legeai J; Worcel M
    Arzneimittelforschung; 1986 Dec; 36(12):1761-7. PubMed ID: 3566836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-arrhythmic action of 4'-methyl-7-([2-hydroxy-3-(beta-propinamidoethyl)amino]propoxy) flavone hydrochloride (SIPI-644)].
    Chen JC; Min Y; Pan XX
    Zhongguo Yao Li Xue Bao; 1988 Mar; 9(2):132-6. PubMed ID: 3188948
    [No Abstract]   [Full Text] [Related]  

  • 18. The actions of N-propyl ajmaline on experimental arrhythmias and electrophysiological properties of the heart.
    Shigenobu K; Kasuya Y; Ishiko J; Fukuda H
    Chem Pharm Bull (Tokyo); 1974 Oct; 22(10):2329-36. PubMed ID: 4468084
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The antiarrhythmic effect of intravenous 17-monochloroacetyl-ajmaline. A review of 50 treated cases].
    Fiol Sala M
    Med Clin (Barc); 1983 Jun; 81(3):105-8. PubMed ID: 6888063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.